InvestorsHub Logo
Post# of 252587
Next 10
Followers 831
Posts 120032
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 96906

Wednesday, 07/28/2010 6:18:10 AM

Wednesday, July 28, 2010 6:18:10 AM

Post# of 252587
FDA grants priority review for Merck KGaA’s Cladribine in RRMS:

http://www.reuters.com/article/idCNN2720940320100727

The PDUFA date is on or about 12/5/10 (Merck KGaA is not disclosing the exact date).

A decision on Cladribine from the EMA is expected in 3Q10. The MAA was submitted in Jul 2009 (#msg-39836037).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.